{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:50:33Z","timestamp":1788306633025,"version":"build-2803163510"},"reference-count":130,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.rdc.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T16:33:05Z","timestamp":1379781185000},"page":"701-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Monogenic Autoinflammatory Diseases"],"prefix":"10.1016","volume":"39","author":[{"given":"Gina A.","family":"Montealegre Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Almeida de","family":"Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaela","family":"Goldbach-Mansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2013.08.001_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: a clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.rdc.2013.08.001_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","author":"Consortium","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever","volume":"90","author":"Consortium","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.rdc.2013.08.001_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.rdc.2013.08.001_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib6","first-page":"525","article-title":"Mevalonate kinase deficiency and Dutch type periodic fever","volume":"18","author":"Frenkel","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.rdc.2013.08.001_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","article-title":"A hypermorphic missense mutation in PLCG2, encoding phospholipase Cgamma2, causes a dominantly inherited autoinflammatory disease with immunodeficiency","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder","volume":"11","author":"Wise","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib11","first-page":"567","article-title":"Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis","volume":"22","author":"Henderson","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2013.08.001_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.rdc.2013.08.001_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","article-title":"Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases","volume":"117","author":"Martinon","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.rdc.2013.08.001_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.rdc.2013.08.001_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2005.02.007","article-title":"The CATERPILLER family: an ancient family of immune\/apoptotic proteins","volume":"115","author":"Ting","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rdc.2013.08.001_bib18","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.4049\/jimmunol.1203162","article-title":"Molecular basis of DNA recognition in the immune system","volume":"190","author":"Atianand","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2013.08.001_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.rdc.2013.08.001_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature02664","article-title":"Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf","volume":"430","author":"Mariathasan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2013.08.001_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.rdc.2013.08.001_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00056-X","article-title":"Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis","volume":"11","author":"Chae","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.rdc.2013.08.001_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.rdc.2013.08.001_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.coi.2012.12.004","article-title":"Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments","volume":"25","author":"Haneklaus","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.rdc.2013.08.001_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.rdc.2013.08.001_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature11588","article-title":"The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP","volume":"492","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2013.08.001_bib28","doi-asserted-by":"crossref","first-page":"39320","DOI":"10.1074\/jbc.M104730200","article-title":"Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis","volume":"276","author":"Richards","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2013.08.001_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2011.02.020","article-title":"Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice","volume":"34","author":"Chae","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.rdc.2013.08.001_bib30","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2008-03-144667","article-title":"HMG-CoA reductase inhibition induces IL-1beta release through Rac1\/PI3K\/PKB-dependent caspase-1 activation","volume":"112","author":"Kuijk","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2013.08.001_bib31","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","article-title":"A role for geranylgeranylation in interleukin-1beta secretion","volume":"54","author":"Mandey","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib32","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2005-11-006783","article-title":"Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS)","volume":"108","author":"Lobito","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2013.08.001_bib33","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1073\/pnas.0914118107","article-title":"Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome","volume":"107","author":"Simon","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rdc.2013.08.001_bib34","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib35","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib36","doi-asserted-by":"crossref","first-page":"29968","DOI":"10.1074\/jbc.M109.023663","article-title":"A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2","volume":"284","author":"Donkor","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2013.08.001_bib37","doi-asserted-by":"crossref","first-page":"29074","DOI":"10.1074\/jbc.M111.258798","article-title":"Phosphatidate phosphatase activity plays key role in protection against fatty acid-induced toxicity in yeast","volume":"286","author":"Fakas","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2013.08.001_bib38","doi-asserted-by":"crossref","first-page":"10894","DOI":"10.1074\/jbc.M112.342915","article-title":"Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages","volume":"287","author":"Valdearcos","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2013.08.001_bib39","unstructured":"Infevers: an online database for autoinflammatory mutations. Available at: http:\/\/fmf.igh.cnrs.fr\/ISSAID\/infevers\/. Accessed May 20, 2013."},{"key":"10.1016\/j.rdc.2013.08.001_bib40","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/341357","article-title":"Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes","volume":"71","author":"Feldmann","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib42","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/art.30512","article-title":"High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study","volume":"63","author":"Tanaka","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib43","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1002\/art.20633","article-title":"Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1\/PYPAF1\/NALP3 gene","volume":"50","author":"Arostegui","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib44","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1185\/03007990802081543","article-title":"Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives","volume":"24","author":"Stych","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rdc.2013.08.001_bib45","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/340786","article-title":"New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes","volume":"70","author":"Dode","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib47","first-page":"235","article-title":"Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome","volume":"31","author":"Muckle","year":"1962","journal-title":"Q J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib48","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.10509","article-title":"Association of mutations in the NALP3\/CIAS1\/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis","volume":"46","author":"Aganna","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib50","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/art.34409","article-title":"Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes","volume":"64","author":"Sibley","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00247-006-0358-0","article-title":"Arthropathy of neonatal onset multisystem inflammatory disease (NOMID\/CINCA)","volume":"37","author":"Hill","year":"2007","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.rdc.2013.08.001_bib52","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.clinthera.2012.09.009","article-title":"Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study","volume":"34","author":"Hoffman","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.rdc.2013.08.001_bib53","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib54","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib55","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib56","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.08.001_bib57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib58","article-title":"MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease","author":"Stoffels","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.08.001_bib59","first-page":"718","article-title":"Ethnic distribution and amyloidosis in familial Mediterranean fever (FMF)","volume":"24","author":"Heller","year":"1961","journal-title":"Pathol Microbiol (Basel)"},{"key":"10.1016\/j.rdc.2013.08.001_bib60","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","article-title":"Familial Mediterranean fever","volume":"351","author":"Ben-Chetrit","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2013.08.001_bib61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2141.2009.07733.x","article-title":"Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy","volume":"146","author":"Chae","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rdc.2013.08.001_bib62","first-page":"1708","article-title":"Protracted febrile myalgia in patients with familial Mediterranean fever","volume":"21","author":"Langevitz","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0887-8994(93)90068-N","article-title":"Neurologic manifestations in familial Mediterranean fever","volume":"9","author":"Gedalia","year":"1993","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.rdc.2013.08.001_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000152370.84628.0c","article-title":"Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study","volume":"84","author":"Tunca","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2013.08.001_bib65","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/art.22507","article-title":"Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever","volume":"56","author":"Touitou","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib66","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib67","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib68","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ndt\/gfn646","article-title":"Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation","volume":"24","author":"Moser","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rdc.2013.08.001_bib69","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","article-title":"Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial","volume":"157","author":"Hashkes","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","article-title":"Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature","volume":"41","author":"Meinzer","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib71","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine","volume":"38","author":"Ozen","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib72","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/ard.2010.146878","article-title":"The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis","volume":"70","author":"Mitroulis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.08.001_bib73","first-page":"S99","article-title":"Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents","volume":"24","author":"Seyahi","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib74","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10067-012-2009-1","article-title":"Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up","volume":"31","author":"Ozcakar","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2013.08.001_bib76","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00431-008-0685-2","article-title":"TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept","volume":"167","author":"Jesus","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.rdc.2013.08.001_bib77","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/321976","article-title":"The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers","volume":"69","author":"Aksentijevich","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib78","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","article-title":"Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study","volume":"64","author":"Bulua","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib79","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","article-title":"Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib80","first-page":"357","article-title":"Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy","volume":"35","author":"Sacre","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib81","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2010.144279","article-title":"Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome","volume":"70","author":"Quillinan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.08.001_bib82","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","article-title":"Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome","volume":"9","author":"Cuisset","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group","volume":"73","author":"Drenth","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2013.08.001_bib84","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/rheumatology\/kem200","article-title":"Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome","volume":"46","author":"Ammouri","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.08.001_bib85","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rdc.2013.08.001_bib86","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: a survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.rdc.2013.08.001_bib87","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2013.08.001_bib88","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","article-title":"Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome","volume":"48","author":"Takada","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","article-title":"Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome","volume":"27","author":"Rigante","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2013.08.001_bib90","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/rheumatology\/kes097","article-title":"Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency","volume":"51","author":"Galeotti","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.08.001_bib91","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/jmg.2005.030759","article-title":"Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome)","volume":"42","author":"Ferguson","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib92","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-3476(89)80650-X","article-title":"Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings","volume":"115","author":"Majeed","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.rdc.2013.08.001_bib93","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/BOR.0b013e32825f5492","article-title":"Autoinflammatory bone disorders","volume":"19","author":"Ferguson","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib94","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1002\/art.30588","article-title":"A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil","volume":"63","author":"Jesus","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2013.08.001_bib95","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/annrheumdis-2012-201818","article-title":"Efficacy of anti-IL-1 treatment in Majeed syndrome","volume":"72","author":"Herlin","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.08.001_bib96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib97","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","article-title":"Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome","volume":"105","author":"Kanazawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2013.08.001_bib98","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/art.24533","article-title":"NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain","volume":"60","author":"Rose","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/BOR.0b013e328349c430","article-title":"Blau syndrome revisited","volume":"23","author":"Rose","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib100","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/art.22966","article-title":"NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort","volume":"56","author":"Arostegui","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib101","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1074\/jbc.273.10.5765","article-title":"Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein","volume":"273","author":"Wu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2013.08.001_bib102","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rdc.2013.08.001_bib103","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2007.08.029","article-title":"Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants","volume":"28","author":"Yu","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.rdc.2013.08.001_bib104","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1074\/jbc.M112.443077","article-title":"Inflammation in mice ectopically expressing human Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome-associated PSTPIP1 A230T mutant proteins","volume":"288","author":"Wang","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2013.08.001_bib105","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.34332","article-title":"Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)","volume":"64","author":"Demidowich","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib106","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-5793(96)00110-X","article-title":"20S proteasome from LMP7 knock out mice reveals altered proteolytic activities and cleavage site preferences","volume":"383","author":"Stohwasser","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.rdc.2013.08.001_bib107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000334283","article-title":"Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting","volume":"10","author":"Ciechanover","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.rdc.2013.08.001_bib108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1042\/BST0350012","article-title":"Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy","volume":"35","author":"Goldberg","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.rdc.2013.08.001_bib109","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2010.07.036","article-title":"Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress","volume":"142","author":"Seifert","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.rdc.2013.08.001_bib110","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ajhg.2010.10.031","article-title":"PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome","volume":"87","author":"Agarwal","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib111","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1073\/pnas.1106015108","article-title":"Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome","volume":"108","author":"Arima","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rdc.2013.08.001_bib112","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1172\/JCI58414","article-title":"A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans","volume":"121","author":"Kitamura","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2013.08.001_bib113","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib114","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1469-8749.2012.04437.x","article-title":"Recognizable phenotypes associated with intracranial calcification","volume":"55","author":"Livingston","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.rdc.2013.08.001_bib115","first-page":"77","article-title":"Secondary hypertrophic osteoperiostosis with pernio","volume":"45","author":"Nakajo","year":"1939","journal-title":"J Derm Urol"},{"key":"10.1016\/j.rdc.2013.08.001_bib116","first-page":"136","article-title":"Hypertrophic pulmonary osteo-arthropathy with pernio-like eruption in the two families: report of the three cases","volume":"60","author":"Nishimura","year":"1950","journal-title":"Jpn J Derm Venereol"},{"key":"10.1016\/j.rdc.2013.08.001_bib117","first-page":"1084","article-title":"An unknown autoinflammatory syndrome associated with short stature and dysmorphic features in a young boy","volume":"29","author":"Megarbane","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib118","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1210\/jc.2010-0488","article-title":"An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy","volume":"95","author":"Garg","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rdc.2013.08.001_bib119","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome","volume":"62","author":"Torrelo","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2013.08.001_bib120","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib121","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib122","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","article-title":"Familial pityriasis rubra pilaris is caused by mutations in CARD14","volume":"91","author":"Fuchs-Telem","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib123","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rdc.2013.08.001_bib124","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1084\/jem.20070157","article-title":"Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation","volume":"204","author":"Blumberg","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2350-5-4","article-title":"Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects","volume":"5","author":"Medlej-Hashim","year":"2004","journal-title":"BMC Med Genet"},{"issue":"Suppl 10","key":"10.1016\/j.rdc.2013.08.001_bib126","first-page":"310","article-title":"Pathogenesis Study of Infantile-Onset, Severe Pustular Psoriasis Reveals a De Novo Mutation in CARD14 Causing Psoriasis Which Responds Clinically to IL-12\/23 Blocking Treatment with Ustekinumab. [abstract]","volume":"63","author":"Habal","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.08.001_bib127","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2013.08.001_bib128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2012.04.045","article-title":"Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy","volume":"143","author":"Kotlarz","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.rdc.2013.08.001_bib129","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2012.09.025","article-title":"Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation","volume":"131","author":"Engelhardt","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rdc.2013.08.001_bib130","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.2457","article-title":"Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency","volume":"13","author":"Boisson","year":"2012","journal-title":"Nat Immunol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:12:10Z","timestamp":1760181130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0889857X13000744"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.08.001","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monogenic Autoinflammatory Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}